[go: up one dir, main page]

BRPI1016038A2 - método para tratar neurodegeneração causada pela síndrome de compressão do nervo ou neuropatia de encarceramento. - Google Patents

método para tratar neurodegeneração causada pela síndrome de compressão do nervo ou neuropatia de encarceramento.

Info

Publication number
BRPI1016038A2
BRPI1016038A2 BRPI1016038A BRPI1016038A BRPI1016038A2 BR PI1016038 A2 BRPI1016038 A2 BR PI1016038A2 BR PI1016038 A BRPI1016038 A BR PI1016038A BR PI1016038 A BRPI1016038 A BR PI1016038A BR PI1016038 A2 BRPI1016038 A2 BR PI1016038A2
Authority
BR
Brazil
Prior art keywords
incarceration
neuropathy
nerve compression
compression syndrome
neurodegeneration caused
Prior art date
Application number
BRPI1016038A
Other languages
English (en)
Inventor
Henrich Cheng
Ming-Jei Lo
Yee-Chiang Liu
Original Assignee
Eu Sol Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eu Sol Biotech Co Ltd filed Critical Eu Sol Biotech Co Ltd
Publication of BRPI1016038A2 publication Critical patent/BRPI1016038A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
BRPI1016038A 2009-08-14 2010-08-16 método para tratar neurodegeneração causada pela síndrome de compressão do nervo ou neuropatia de encarceramento. BRPI1016038A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23398709P 2009-08-14 2009-08-14
PCT/CN2010/001240 WO2011017915A1 (en) 2009-08-14 2010-08-16 Method for repairing neurodegeneration

Publications (1)

Publication Number Publication Date
BRPI1016038A2 true BRPI1016038A2 (pt) 2016-07-05

Family

ID=43585895

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1016038A BRPI1016038A2 (pt) 2009-08-14 2010-08-16 método para tratar neurodegeneração causada pela síndrome de compressão do nervo ou neuropatia de encarceramento.

Country Status (13)

Country Link
US (2) US9198953B2 (pt)
EP (1) EP2464376B1 (pt)
JP (1) JP2013501736A (pt)
KR (1) KR20120051605A (pt)
CN (1) CN102497876A (pt)
AU (1) AU2010282105B9 (pt)
BR (1) BRPI1016038A2 (pt)
CA (1) CA2765265A1 (pt)
IL (1) IL215986A0 (pt)
MX (1) MX2012001908A (pt)
NZ (1) NZ596075A (pt)
TW (1) TWI434698B (pt)
WO (1) WO2011017915A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110280838A1 (en) * 2007-12-27 2011-11-17 Advanced Technologies And Regenerative Medicine, Llc Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
TWI634898B (zh) * 2013-10-07 2018-09-11 雅祥生技醫藥股份有限公司 經修飾之人類酸性纖維母細胞生長因子及其組合物
PL3107551T3 (pl) * 2014-02-18 2021-05-04 Glenn Abrahmsohn Kompozycje zawierające sole wodorowęglanowe i wapniowe do uśmierzania bólu bez odrętwienia
US20190125836A1 (en) * 2017-10-31 2019-05-02 Eusol Biotech Co., Ltd. USE OF aFGF FOR PREVENTING OR TREATING DISEASES RELATED TO MUSCLE WASTING
TWI848060B (zh) * 2019-02-28 2024-07-11 雅祥生技醫藥股份有限公司 重組蛋白用於治療代謝疾病
JP2022551086A (ja) * 2019-10-03 2022-12-07 ヴィトルヴィア ホールディングス インコーポレイテッド 結合組織修復の方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733871A (en) 1991-11-08 1998-03-31 The General Hospital Corporation Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
ATE244584T1 (de) * 1995-01-16 2003-07-15 Baxter Int Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
CA2419203A1 (en) 2000-08-15 2002-02-21 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
AU2001288256B2 (en) 2000-08-15 2006-03-30 New Technologies Holdings Pte Ltd A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
US8146602B2 (en) * 2003-01-29 2012-04-03 Taipei Veterans General Hospital Method and mixture for nerve root repair
JP4505631B2 (ja) * 2004-03-31 2010-07-21 独立行政法人産業技術総合研究所 ヘパラン硫酸糖鎖を付加したヘパリン結合性タンパク質、その製造方法及びそれを含有する医薬組成物
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
WO2007138236A1 (en) * 2006-05-24 2007-12-06 The University Of Birmingham Sheddase enzymes for neuron growth
US20080109035A1 (en) * 2006-10-31 2008-05-08 Henrich Cheng Methods and Compositions for Repairing Common Peroneal Nerve Lesions
US7956033B2 (en) * 2008-06-10 2011-06-07 Eu Sol Biotech Co., Ltd. Modified peptide of human acidic fibroblast growth factor

Also Published As

Publication number Publication date
TW201124154A (en) 2011-07-16
WO2011017915A1 (en) 2011-02-17
CA2765265A1 (en) 2011-02-17
US9198953B2 (en) 2015-12-01
EP2464376A1 (en) 2012-06-20
NZ596075A (en) 2013-06-28
JP2013501736A (ja) 2013-01-17
KR20120051605A (ko) 2012-05-22
EP2464376A4 (en) 2013-02-27
AU2010282105B9 (en) 2015-07-30
EP2464376B1 (en) 2016-10-05
US20160106811A1 (en) 2016-04-21
TWI434698B (zh) 2014-04-21
US20110039774A1 (en) 2011-02-17
AU2010282105B2 (en) 2015-07-23
AU2010282105A1 (en) 2011-11-10
MX2012001908A (es) 2012-03-16
IL215986A0 (en) 2012-01-31
CN102497876A (zh) 2012-06-13

Similar Documents

Publication Publication Date Title
DK2159258T3 (da) Behandlede mineralfyldstofprodukter, fremgangsmåde til fremstilling deraf og anvendelser deraf
BR112012018101A2 (pt) aparelho, e método.
BR112013030520A2 (pt) método, sistema, e, composição.
BR112013015581A2 (pt) método, e. sistema
BRPI1011011A2 (pt) método, sistema de monitoramento, e, produto de programa.
BRPI0910399A2 (pt) aparelho para preparar alimento.
BR112013031378A2 (pt) método, aparelho e sistema para adaptação de rank de uplink.
BR112014008482A2 (pt) sistema, método de perfilação de resistividade
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
BRPI1013625A2 (pt) sistema, e método para determinar saúde de equipamento
BRPI1008004A2 (pt) método para produção de metal, e, aparelho.
DK2639234T3 (da) Krystallinsk 6,7-umættet 7-carbamoylmorphinanderivat og fremgangsmåde til fremstilling heraf
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BRPI0823030A2 (pt) Sistema de elevador, e, método para fazer um sistema de elevador.
BR112012004383A2 (pt) método, aparelho e sistema para predição de espectro
BR112012016424A2 (pt) aparelho, e método.
BRPI1007925A2 (pt) método, e aparelho.
BRPI1009317A2 (pt) aparelho de formação de imagem, método de formação de imagem, e programa.
BR112012010375A2 (pt) aparelho, sistema e método implementado por máquina
BRPI0918736A2 (pt) método para produzir leite modificado.
BRPI0911531A2 (pt) processo para preparar iopromida, e, composto.
BR112013004456A2 (pt) composição para tratamento de planta, e, método para o tratamento de plantas
BRPI0921136A2 (pt) método implementador por computador para processar sinais de medição sequencial de uma região de subsuperficie, e, sistema configurado para processar perfilagens de subsuperficie.
BRPI1011620A2 (pt) composição, composto, e, método de diluição.
BRPI1014100A2 (pt) método, equipamento e sistema para reduzir atraso de mídia.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2475 DE 12-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]